Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 104651-104700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03796884
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
PHASE2
Active, not recruiting
230 participants
Started: Oct 30, 2019 · Completed: Jun 30, 2026
11 conditions
2 sponsors
3 locations
NCT04138927
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
PHASE3
Enrolling by invitation
90 participants
Started: Oct 30, 2019 · Completed: Apr 30, 2024
1 condition
1 sponsor
37 locations
NCT04207177
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
PHASE4
Active, not recruiting
100 participants
Started: Oct 30, 2019 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04088019
Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive
N/A
Recruiting
50 participants
Started: Oct 30, 2019 · Completed: Jul 31, 2024
3 conditions
1 sponsor
1 location
NCT03995082
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
NA
Recruiting
925 participants
Started: Oct 30, 2019 · Completed: Jun 30, 2026
1 condition
2 sponsors
3 locations
NCT03821246
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
PHASE2
Recruiting
68 participants
Started: Oct 30, 2019 · Completed: Apr 30, 2026
3 conditions
3 sponsors
2 locations
NCT04137900
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
PHASE1
Recruiting
499 participants
Started: Oct 30, 2019 · Completed: Mar 31, 2026
2 conditions
3 sponsors
24 locations
NCT06339255
Italian Observational Study on CAR-T Therapy for Lymphoma
N/A
Recruiting
5,300 participants
Started: Oct 30, 2019 · Completed: Dec 31, 2029
4 conditions
4 sponsors
1 location
NCT04094688
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer
PHASE3
Active, not recruiting
455 participants
Started: Oct 29, 2019 · Completed: Jul 1, 2026
1 condition
2 sponsors
1031 locations
NCT04029623
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease
NA
Recruiting
66 participants
Started: Oct 29, 2019 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04157348
Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
PHASE3
Active, not recruiting
140 participants
Started: Oct 29, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
50 locations
NCT05101460
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
N/A
Recruiting
315 participants
Started: Oct 29, 2019 · Completed: Apr 24, 2029
1 condition
1 sponsor
1 location
NCT03804229
Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
PHASE3
Active, not recruiting
707 participants
Started: Oct 29, 2019 · Completed: Feb 7, 2025
1 condition
2 sponsors
1 location
NCT03910738
TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
PHASE2
Recruiting
40 participants
Started: Oct 29, 2019 · Completed: Dec 31, 2027
1 condition
4 sponsors
5 locations
NCT03865082
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
PHASE2
Active, not recruiting
30 participants
Started: Oct 29, 2019 · Completed: Apr 30, 2022
1 condition
2 sponsors
3 locations
NCT04099251
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
PHASE3
Active, not recruiting
790 participants
Started: Oct 28, 2019 · Completed: Jun 29, 2027
1 condition
1 sponsor
130 locations
NCT04304209
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer
PHASE2
Active, not recruiting
195 participants
Started: Oct 28, 2019 · Completed: Oct 18, 2026
2 conditions
1 sponsor
1 location
NCT03781986
APG-115 in Salivary Gland Cancer Trial
PHASE1/PHASE2
Active, not recruiting
41 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2026
2 conditions
2 sponsors
3 locations
NCT04269304
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE
N/A
Active, not recruiting
429 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2025
1 condition
7 sponsors
12 locations
NCT03910452
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
EARLY_PHASE1
Active, not recruiting
4 participants
Started: Oct 28, 2019 · Completed: Jun 15, 2034
1 condition
1 sponsor
1 location
NCT04096443
Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis
EARLY_PHASE1
Active, not recruiting
9 participants
Started: Oct 28, 2019 · Completed: Dec 30, 2024
1 condition
2 sponsors
1 location
NCT04003272
MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere
N/A
Enrolling by invitation
59 participants
Started: Oct 28, 2019 · Completed: Sep 1, 2035
5 conditions
1 sponsor
2 locations
NCT04499534
BRCA1/2 Flu Vaccine
N/A
Active, not recruiting
50 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04069754
Passport to Freedom (P2F): Adaptation and Implementation of a Wellness Program
NA
Active, not recruiting
40 participants
Started: Oct 28, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04136717
Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery
NA
Recruiting
10 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2028
4 conditions
1 sponsor
1 location
NCT04104529
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
NA
Recruiting
350 participants
Started: Oct 28, 2019 · Completed: Oct 31, 2026
3 conditions
1 sponsor
4 locations
NCT06472570
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
NA
Recruiting
80 participants
Started: Oct 26, 2019 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT04006808
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
PHASE1/PHASE2
Recruiting
184 participants
Started: Oct 25, 2019 · Completed: Mar 31, 2027
1 condition
1 sponsor
31 locations
NCT04143516
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
PHASE2/PHASE3
Recruiting
200 participants
Started: Oct 25, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT04132895
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
N/A
Recruiting
300 participants
Started: Oct 25, 2019 · Completed: Jan 31, 2027
1 condition
2 sponsors
22 locations
NCT04116502
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
PHASE3
Recruiting
586 participants
Started: Oct 25, 2019 · Completed: Apr 1, 2030
1 condition
4 sponsors
47 locations
NCT03768570
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
PHASE2
Active, not recruiting
82 participants
Started: Oct 25, 2019 · Completed: Mar 31, 2026
1 condition
2 sponsors
31 locations
NCT03834961
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
PHASE2
Active, not recruiting
31 participants
Started: Oct 25, 2019 · Completed: Mar 25, 2026
5 conditions
2 sponsors
80 locations
NCT04092673
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
PHASE1/PHASE2
Recruiting
30 participants
Started: Oct 25, 2019 · Completed: Mar 31, 2025
1 condition
1 sponsor
14 locations
NCT04166526
A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease
N/A
Recruiting
8 participants
Started: Oct 25, 2019 · Completed: Aug 1, 2026
1 condition
2 sponsors
1 location
NCT04145518
Mechanistic Characterization of Uterine Pain
PHASE4
Recruiting
214 participants
Started: Oct 25, 2019 · Completed: Aug 29, 2025
6 conditions
3 sponsors
1 location
NCT03893916
MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy
NA
Recruiting
100 participants
Started: Oct 25, 2019 · Completed: Apr 25, 2029
3 conditions
1 sponsor
1 location
NCT04101084
Rocking Chair Therapy in Elderly With Dementia: Its Effects on Agitation
NA
Active, not recruiting
12 participants
Started: Oct 25, 2019 · Completed: Apr 18, 2024
1 condition
1 sponsor
1 location
NCT04124848
Obstructive Sleep Apnea Among Somali-Americans
N/A
Recruiting
600 participants
Started: Oct 25, 2019 · Completed: Dec 31, 2031
1 condition
2 sponsors
1 location
NCT04777045
Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial
PHASE3
Active, not recruiting
85 participants
Started: Oct 25, 2019 · Completed: Dec 31, 2026
3 conditions
1 sponsor
3 locations
NCT04064177
Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study
N/A
Recruiting
148 participants
Started: Oct 24, 2019 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT04144972
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
NA
Recruiting
12 participants
Started: Oct 24, 2019 · Completed: Oct 24, 2030
9 conditions
2 sponsors
1 location
NCT04341571
Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.
PHASE2
Active, not recruiting
30 participants
Started: Oct 24, 2019 · Completed: Jul 31, 2025
4 conditions
1 sponsor
1 location
NCT04008368
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
PHASE1/PHASE2
Recruiting
32 participants
Started: Oct 24, 2019 · Completed: Dec 1, 2037
1 condition
1 sponsor
1 location
NCT03995108
Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome
PHASE3
Active, not recruiting
31 participants
Started: Oct 24, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
23 locations
NCT03924661
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
N/A
Active, not recruiting
20 participants
Started: Oct 24, 2019 · Completed: Oct 31, 2028
1 condition
1 sponsor
13 locations
NCT05730647
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
N/A
Active, not recruiting
600 participants
Started: Oct 24, 2019 · Completed: Jul 31, 2032
1 condition
1 sponsor
40 locations
NCT04151433
Conservative Endometrioma Surgery
NA
Recruiting
92 participants
Started: Oct 24, 2019 · Completed: Dec 31, 2026
2 conditions
4 sponsors
4 locations
NCT04016402
Imaging to Improve Brain Stimulation
N/A
Active, not recruiting
42 participants
Started: Oct 24, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
2 locations
NCT04052880
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
PHASE2
Active, not recruiting
17 participants
Started: Oct 24, 2019 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
2091
2092
2093
2094
2095
2096
2097
More pages
2369
Next